DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Mandanas S, Mathiopoulou L, Boudina M. et al.
Loss of Efficacy of Pasireotide after its Re-Administration: is There a Reason Why?.
Rare Tumors 2016;
8: 173-175
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.